Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group - Takeaways - MDSpire

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group

  • By

  • Pietro Diana

  • Tobias Klatte

  • Daniele Amparore

  • Riccardo Bertolo

  • Umberto Carbonara

  • Selcuk Erdem

  • Alexandre Ingels

  • Onder Kara

  • Laura Marandino

  • Michele Marchioni

  • Stijn Muselaers

  • Nicola Pavan

  • Angela Pecoraro

  • Alessio Pecoraro

  • Eduard Roussel

  • Riccardo Campi

  • April 1, 2022

  • 0 min

Share

  • 1

    The incidence of renal cell carcinoma (RCC) is rising, with over 430,000 new cases and 175,000 deaths globally in 2020.

  • 2

    Established risk factors for RCC include older age, male sex, smoking, hypertension, and obesity.

  • 3

    Screening programs for RCC could improve early detection, survival outcomes, and reduce healthcare costs.

  • 4

    Focused renal ultrasound is a cost-effective screening tool, but other non-invasive diagnostics lack clinical validation.

  • 5

    Uncertainties remain regarding the benefits, cost-effectiveness, and potential harms of RCC screening programs.

Original Source(s)

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group

  • by Pietro Diana, Tobias Klatte, Daniele Amparore, Riccardo Bertolo, Umberto Carbonara, Selcuk Erdem, Alexandre Ingels, Onder Kara, Laura Marandino, Michele Marchioni, Stijn Muselaers, Nicola Pavan, Angela Pecoraro, Alessio Pecoraro, Eduard Roussel, Riccardo Campi

  • April 1, 2022

Related Content

Vesicovaginal reflux: a case report and literature overview

Correction: MRI-based habitat radiomics for predicting WHO/ISUP nuclear grade in clear cell renal cell carcinoma

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report